NuvOx Therapeutics, Inc. (NUOX)
SEC: NUOX · CIK 0001966126 · United States
Every official NuvOx Therapeutics, Inc. filing in one place: annual reports, quarterly results, current reports,
proxy statements, shareholding and announcements, straight from the regulator. Free to search.
Open NUOX filings
NuvOx Therapeutics, Inc. documents
- NuvOx Therapeutics, Inc. 10-K 2026NUOX 10-K 2026: annual report for fiscal 2026
- NuvOx Therapeutics, Inc. 10-K 2025NUOX 10-K 2025: annual report for fiscal 2025
- NuvOx Therapeutics, Inc. 10-K 2024NUOX 10-K 2024: annual report for fiscal 2024
- NuvOx Therapeutics, Inc. 10-K 2023NUOX 10-K 2023: annual report for fiscal 2023
- NuvOx Therapeutics, Inc. 10-K 2022NUOX 10-K 2022: annual report for fiscal 2022
- NuvOx Therapeutics, Inc. 10-Q 2026NUOX 10-Q 2026: quarterly report for fiscal 2026
- NuvOx Therapeutics, Inc. 10-Q 2025NUOX 10-Q 2025: quarterly report for fiscal 2025
- NuvOx Therapeutics, Inc. 10-Q 2024NUOX 10-Q 2024: quarterly report for fiscal 2024
- NuvOx Therapeutics, Inc. 10-Q 2023NUOX 10-Q 2023: quarterly report for fiscal 2023
- NuvOx Therapeutics, Inc. 10-Q 2022NUOX 10-Q 2022: quarterly report for fiscal 2022
- NuvOx Therapeutics, Inc. 8-K 2026NUOX 8-K 2026: current report for fiscal 2026
- NuvOx Therapeutics, Inc. 8-K 2025NUOX 8-K 2025: current report for fiscal 2025
- NuvOx Therapeutics, Inc. 8-K 2024NUOX 8-K 2024: current report for fiscal 2024
- NuvOx Therapeutics, Inc. 8-K 2023NUOX 8-K 2023: current report for fiscal 2023
- NuvOx Therapeutics, Inc. 8-K 2022NUOX 8-K 2022: current report for fiscal 2022
- NuvOx Therapeutics, Inc. DEF 14A 2026NUOX DEF 14A 2026: proxy statement for fiscal 2026
- NuvOx Therapeutics, Inc. DEF 14A 2025NUOX DEF 14A 2025: proxy statement for fiscal 2025
- NuvOx Therapeutics, Inc. DEF 14A 2024NUOX DEF 14A 2024: proxy statement for fiscal 2024
- NuvOx Therapeutics, Inc. DEF 14A 2023NUOX DEF 14A 2023: proxy statement for fiscal 2023
- NuvOx Therapeutics, Inc. DEF 14A 2022NUOX DEF 14A 2022: proxy statement for fiscal 2022
- NuvOx Therapeutics, Inc. Form 4 2026NUOX Form 4 2026: insider trading filing for fiscal 2026
- NuvOx Therapeutics, Inc. Form 4 2025NUOX Form 4 2025: insider trading filing for fiscal 2025
- NuvOx Therapeutics, Inc. Form 4 2024NUOX Form 4 2024: insider trading filing for fiscal 2024
- NuvOx Therapeutics, Inc. Form 4 2023NUOX Form 4 2023: insider trading filing for fiscal 2023
- NuvOx Therapeutics, Inc. Form 4 2022NUOX Form 4 2022: insider trading filing for fiscal 2022
- NuvOx Therapeutics, Inc. S-1 2026NUOX S-1 2026: registration statement for fiscal 2026
- NuvOx Therapeutics, Inc. S-1 2025NUOX S-1 2025: registration statement for fiscal 2025
- NuvOx Therapeutics, Inc. S-1 2024NUOX S-1 2024: registration statement for fiscal 2024
- NuvOx Therapeutics, Inc. S-1 2023NUOX S-1 2023: registration statement for fiscal 2023
- NuvOx Therapeutics, Inc. S-1 2022NUOX S-1 2022: registration statement for fiscal 2022
- NuvOx Therapeutics, Inc. 13F 2026NUOX 13F 2026: institutional holdings for fiscal 2026
- NuvOx Therapeutics, Inc. 13F 2025NUOX 13F 2025: institutional holdings for fiscal 2025
- NuvOx Therapeutics, Inc. 13F 2024NUOX 13F 2024: institutional holdings for fiscal 2024
- NuvOx Therapeutics, Inc. 13F 2023NUOX 13F 2023: institutional holdings for fiscal 2023
- NuvOx Therapeutics, Inc. 13F 2022NUOX 13F 2022: institutional holdings for fiscal 2022
More companies